Design and Implementation of Intelligent Home Control System Based on Android and Arduino

作为时下最炙手可热的移动应用端操作系统,Android以其显著的开放性、便于开发的灵活性、能够与Google应用的无缝对接性及丰富的第三方软硬件; 资源等成为智能应用系统不可或缺的组成部分;Arduino单片机系统以其开源的电子原型平台、灵活便捷的设计和丰富的传感器资源等被广泛应用。其与Ja; va和C语言相类似的基于; Wiring/Processing的语言开发环境更是受到越来越多的电子爱好者和开发者的青睐。本文以移动手机安卓系统为无线控制终端,结合Ardui; no单片机系统,设计并实验仿真了一款基于Android与Arduino的智能家居控制系统,以控制; LED灯示例,通过网络http传输控制指令到Arduino单片机系统,Arduino根据所接收到的指令,控制不同的家居电器完成所要求的工作任务。; 仿真实验表明,文章所设计方法行之有效,可以灵活的运用到日常家居电器设备,提供了一种智能家居系统设计的新思路,具有易实现,应用广的特点。As one of the most sought-after mobile application terminal operating; system, Android has become an indispensable part of the intelligent; application system, because it has the features of definite openness,; flexibility for development, perfect connection with Google applications; and abundant third party software and hardware resources and so on.; Arduino MCU system is widely used in society because of its; characteristics of open source electronic prototype platform, flexible; and convenient design, rich sensor resources, etc. Moreover, its classes; Java and C language based on Wiring/Processing development environment; are becoming more and more popular among the electronics enthusiasts and; developers. Taking the mobile phone Android system as wireless control; terminal, and combining Arduino MCU system, an intelligent home control; system based on Android and Arduino is designed and implemented in this; paper. By controlling LED lamp samples, with the network HTTP; transmission control instructions sending to the Arduino MCU system, and; according to the received instructions, Arduino can control different; household electrical appliances to complete the required tasks.; Experiments show that the methods designed in this paper can be flexibly; applied to daily household appliances, such as, home appliance control,; security equipment, etc. This paper provides a new idea for the design; of intelligent home system, which is easy to implement and widely used.2015年度"福建省高校杰出青年科研人才培育计划"项目; 2015年福建省高等学校创新创业教育改革项目;; 2016年本科高校重大教育教学改革研究项目; 2016年省级互联网实验教学示范中心项目; 2016年福建省高等学校服务产业特色专业建设项

Design and Implementation of HDMI CEC in Android TV System

近些年来，智能化的手机、电视、科技家居逐渐的被广大民众所熟悉并使用，这些智能化的设备慢慢的改变的人们的生活方式。智能化设备的普及，离不开功能强大的Android系统。Android系统是近些年来最热门的系统之一，除了占领了手机市场的半壁江山外，已经开始逐步向TV系统渗透，越来越多的电视厂商已经开始采用Android系统。 目前市面上的电视，高分辨率已经成为了主要潮流，从主流的1920*1080P高清分辨率，开始迈向了4K*2K超高清分辨率时代。高清晰度电视(HighDefinitionTelevision)的流行，也使得HDMI(High-DefinitionMultimediaInterf...In recent years,Mobile phones, TV, science and technology of the intelligent home gradually was familiar with and use by the general public, the intelligent equipment gradually changing people's way of life. The popularity of intelligent equipment is inseparable from the powerful Android system. The Android system is one of the most popular system in recent years, nn addition to occupied half of ...学位：工程硕士院系专业：信息科学与技术学院_工程硕士(计算机技术)学号：X201022102

武隆鸡尾山滑坡形成机理数值模拟研究

2009年发生的重庆武隆鸡尾山滑坡,因滑源区斜坡岩层整体缓倾山内,缺乏有效的临空面和滑移空间,因此,在滑坡孕育过程中存在前缘岩溶带压缩变形、底部剪切滑移、后缘拉裂以及最终前缘关键块体(岩溶带)侧向剪断滑出等一系列的复杂动力学行为。这一过程存在显著的连续变形向非连续变形的过渡与转化,单纯用连续介质的有限元和离散介质的离散元来分析模拟都很难取得较好的效果。为探究鸡尾山滑坡的孕育过程和失稳机理,运用将连续–非连续单元有机耦合的大型数值模拟软件CDEM,模拟鸡尾山滑坡的失稳过程和形成机制。研究表明:滑体前方岩溶发育带具有"可压缩性",为滑体运动提供了一定的变形空间;滑源区下方的采矿活动产生应力重分布,滑带抗剪强度降低,滑体沿其底部软弱带发生剪切蠕滑,并逐渐形成滑体后缘拉裂缝;滑动块体在向前滑移过程中不断挤压向前缘"易压缩带",坡体应力自组织调整,并逐渐在前部三角区形成垂直的第二破裂面,前缘抗力体(关键块体)形成,最后剪断岩溶带个别与稳定山体咬合岩块,整体失稳破坏。数值模拟结果较好地揭示了武隆鸡尾山滑坡前缘视倾向展布岩溶带"软基效应"所提供"准临空面",重现了鸡尾山滑坡"蠕滑—拉裂—压缩(压碎)—剪切滑出"的致灾机理

BnGID1基因过量表达对甘蓝型油菜矮化突变体NDF-1株高的恢复

在正常株高油菜中克隆了与拟南芥矮化突变相关基因AtGID1同源的BnGID1基因全长cDNA目的片段,将其正向插入表达载体pFGC5941上的CaMV35S启动子下游,构成该基因过量表达载体pFGC5941-BnGID1.经根癌农杆菌介导,导入甘蓝型油菜矮化突变体NDF-1基因组,通过PCR及半定量RT-PCR检测,确定得到抗性转基因植株23株.移至大田生长,观察结果显示,转基因植株明显高于对照矮化突变体NDF-1,平均高出49.05cm.结果表明,BnGID1基因过量表达能够使甘蓝型油菜矮化突变体NDF-1株高得到较大程度的恢复.图7表2参1

Aripiprazole versus other atypical antipsychotics for schizophrenia

BACKGROUND: In most western industrialised countries, second generation (atypical) antipsychotics are recommended as first line drug treatments for people with schizophrenia. In this review we specifically examine how the efficacy and tolerability of one such agent - aripiprazole - differs from that of other comparable second generation antipsychotics. OBJECTIVES: To evaluate the effects of aripiprazole compared with other atypical antipsychotics for people with schizophrenia and schizophrenia-like psychoses. SEARCH METHODS: We searched the Cochrane Schizophrenia Group Trials Register (November 2011), inspected references of all identified studies for further trials, and contacted relevant pharmaceutical companies, drug approval agencies and authors of trials for additional information. SELECTION CRITERIA: We included all randomised clinical trials (RCTs) comparing aripiprazole (oral) with oral and parenteral forms of amisulpride, clozapine, olanzapine, quetiapine, risperidone, sertindole, ziprasidone or zotepine for people with schizophrenia or schizophrenia-like psychoses. DATA COLLECTION AND ANALYSIS: We extracted data independently. For dichotomous data we calculated risk ratios (RR) and their 95% confidence intervals (CI) on an intention-to-treat basis based on a random-effects model. Where possible, we calculated illustrative comparative risks for primary outcomes. For continuous data, we calculated mean differences (MD), again based on a random-effects model. We assessed risk of bias for each included study. MAIN RESULTS: We included 12 trials involving 6389 patients. Aripiprazole was compared to olanzapine, risperidone and ziprasidone. All trials were sponsored by an interested drug manufacturer. The overall number of participants leaving studies early was 30% to 40%, limiting validity (no differences between groups).When compared with olanzapine no differences were apparent for global state (no clinically important change: n = 703, 1 RCT, RR short-term 1.00 95% CI 0.81 to 1.22; n = 317, 1 RCT, RR medium-term 1.08 95% CI 0.95 to 1.22) but mental state tended to favour olanzapine (n = 1360, 3 RCTs, MD total Positive and Negative Syndrome Scale (PANSS) 4.68 95% CI 2.21 to 7.16). There was no significant difference in extrapyramidal symptoms (n = 529, 2 RCTs, RR 0.99 95% CI 0.62 to 1.59) but fewer in the aripiprazole group had increased cholesterol levels (n = 223, 1 RCT, RR 0.32 95% CI 0.19 to 0.54) or weight gain of 7% or more of total body weight (n = 1095, 3 RCTs, RR 0.39 95% CI 0.28 to 0.54).When compared with risperidone, aripiprazole showed no advantage in terms of global state (n = 384, 2 RCTs, RR no important improvement 1.14 95% CI 0.81 to 1.60) or mental state (n = 372, 2 RCTs, MD total PANSS 1.50 95% CI -2.96 to 5.96).One study compared aripiprazole with ziprasidone (n = 247) and both the groups reported similar change in the global state (n = 247, 1 RCT, MD average change in Clinical Global Impression-Severity (CGI-S) score -0.03 95% CI -0.28 to 0.22) and mental state (n = 247, 1 RCT, MD change PANSS -3.00 95% CI -7.29 to 1.29).When compared with any one of several new generation antipsychotic drugs the aripiprazole group showed improvement in global state in energy (n = 523, 1 RCT, RR 0.69 95% CI 0.56 to 0.84), mood (n = 523, 1 RCT, RR 0.77 95% CI 0.65 to 0.92), negative symptoms (n = 523, 1 RCT, RR 0.82 95% CI 0.68 to 0.99), somnolence (n = 523, 1 RCT, RR 0.80 95% CI 0.69 to 0.93) and weight gain (n = 523, 1 RCT, RR 0.84 95% CI 0.76 to 0.94). Significantly more people given aripiprazole reported symptoms of nausea (n = 2881, 3 RCTs, RR 3.13 95% CI 2.12 to 4.61) but weight gain (7% or more of total body weight) was less common in people allocated aripiprazole (n = 330, 1 RCT, RR 0.35 95% CI 0.19 to 0.64). Aripiprazole may have value in aggression but data are limited. This will be the focus of another review. AUTHORS' CONCLUSIONS: Information on all comparisons are of limited quality, are incomplete and problematic to apply clinically. Aripiprazole is an antipsychotic drug with a variant but not absent adverse effect profile. Long-term data are sparse and there is considerable scope for another update of this review as new data emerges from the many Chinese studies as well as from ongoing larger, independent pragmatic trials